High prevalence of lipid abnormalities among antiretroviral-naive HIV-infected Asian children with mild-to-moderate immunosuppression

Antivir Ther. 2011;16(8):1351-5. doi: 10.3851/IMP1897.

Abstract

Background: Dyslipidaemia is a common complication among HIV-infected children after antiretroviral therapy (ART); however, HIV itself can cause abnormal lipid metabolism. There is limited information of lipid profiles among Asian HIV-infected children naive to ART.

Methods: A total of 274 HIV-infected ART-naive Thai and Cambodian children aged 1-12 years with CD4% between 15% and 24% were included. Patients were fasted for ≥4 h before blood was drawn. Abnormal lipid levels were defined as triglyceride (TG)>130 mg/dl, total cholesterol (TC)>200 mg/dl, low-density lipoprotein (LDL)>130 mg/dl and high-density lipoprotein (HDL)≤40 mg/dl.

Results: The mean (±SD) was 76.6 (33.8) months for age and -1.3 (1.0) for weight Z-score. Mean (±SD) CD4% was 19.9 (4.8) % and HIV RNA was 4.6 (0.6) log(10) copies/ml. The median (±SD) fasting time was 13.0 (2.7) h. Mean (±SD) for lipids were 116 (62) mg/dl for TG, 139 (29) mg/dl for TC, 73 (29) mg/dl for LDL and 45 (19) mg/dl for HDL. Overall 63.9% had dyslipidaemia with hypertriglyceridaemia and hypo-HDL being the most common (28% and 45%, respectively), while 2% had hypercholesterolaemia or hyper-LDL. After adjusting for age, having HIV RNA>5 log(10) copies/ml was associated with hypo-HDL with ORs of 8.1 (95% CI 2.7-24.3).

Conclusions: Up to two-thirds of ART-naive, HIV-infected Asian children with mild-to-moderate immune suppression had dyslipidaemia. Low HDL was the most common and was associated with high HIV viraemia. The long-term consequence of low HDL deserves further investigation in children.

Trial registration: ClinicalTrials.gov NCT00234091.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4 Antigens / immunology*
  • CD4 Lymphocyte Count
  • Cambodia / epidemiology
  • Child
  • Child, Preschool
  • Cholesterol / blood
  • Dyslipidemias / blood*
  • Dyslipidemias / complications
  • Dyslipidemias / epidemiology
  • Dyslipidemias / immunology
  • Dyslipidemias / virology
  • Female
  • HIV Infections / blood*
  • HIV Infections / complications
  • HIV Infections / epidemiology
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV-1 / physiology*
  • Humans
  • Immunocompromised Host*
  • Infant
  • Lipid Metabolism / immunology*
  • Lipoproteins, HDL / blood
  • Lipoproteins, LDL / blood
  • Male
  • Prevalence
  • RNA, Viral / analysis
  • Thailand / epidemiology
  • Triglycerides / blood
  • Viral Load / immunology

Substances

  • CD4 Antigens
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • RNA, Viral
  • Triglycerides
  • Cholesterol

Associated data

  • ClinicalTrials.gov/NCT00234091